Chemistry:Botiacrine
From HandWiki
Botiacrine (INN; developmental code name Mo 876) is a drug of the tricyclic family described as an antiparkinsonian agent which was either never marketed or was possibly marketed outside of the United States.[1][2][3][4][5] It was first described in the literature by 1965.[1] The drug is an acridine derivative and is structurally related to the tricyclic antidepressant dimetacrine.[1]
References
- ↑ 1.0 1.1 1.2 The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. 2014. p. 170. ISBN 978-1-4757-2085-3. https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA170. Retrieved 20 October 2024.
- ↑ Organic-chemical Drugs and Their Synonyms: (an International Survey). Akad.-Verlag. 1994. p. 1768. ISBN 978-3-05-500156-7. https://books.google.com/books?id=SwltAAAAMAAJ&q=botiacrine. Retrieved 20 October 2024.
- ↑ Unlisted Drugs. Unlisted Drugs Committee of the Pharmaceutical Section, Science-Technology Group, Special Libraries Association. 1977. pp. 112–113. https://books.google.com/books?id=_xdtAAAAMAAJ&q=botiacrine. Retrieved 20 October 2024.
- ↑ "BOTIACRINE". https://drugs.ncats.io/substance/032WJR708Q.
- ↑ Publishing, W.A.W.A. (2013). Pharmaceutical Manufacturing Encyclopedia. Volumes 1-4. William Andrew. pp. 657–658. ISBN 978-0-8155-1856-3. https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA657. Retrieved 20 October 2024.
 |  |
